| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . |
# |
Score |
Template |
Links and tools | %id | First |
GLTDALKRSFRLKYELDQSVLINGVKECLSDSAGGLVRTVAYRLLRHSLVDYSSAQLYNSYGINIYLIRSLARDSSDQLEKEQAVFFIRALVDLGNPHGLFIDQSIVRAIISIAENGDDSLRYFCLELLAEIAILDMELLSKSQGLNILLSALTGSSPDLAHFAPVVASIFCYTLDHPSTRKYIKPGTDLEVSMTAFTDVPSAHFKASNARIERLKCANSILVVLLKNWSGLLYFCVNDRNTVRTLIDALRVPSQELREALLDLMFELLIIKTPDWYVASLEGRRQTMYNRSTGQRKAPERSAQDSDKPEKITIIDHYIALLLVVLIDGGLIEGLTAIVEEKNQVLTRKATLLLGELLRKGNRILP | Last |
1 | -105.000 | PF14664.6; R9ABX2_WALI9/151-516; Rapamycin-insensitive companion of mTOR, N-term |
ali |
100 | 1 | GLTDALKRSFRLKYELDQSVLINGVKECLSDSAGGLVRTVAYRLLRHSLVDYSSAQLYNSYGINIYLIRSLARDSSDQLEKEQAVFFIRALVDLGNPHGLFIDQSIVRAIISIAENGDDSLRYFCLELLAEIAILDMELLSKSQGLNILLSALTGSSPDLAHFAPVVASIFCYTLDHPSTRKYIKPGTDLEVSMTAFTDVPSAHFKASNARIERLKCANSILVVLLKNWSGLLYFCVNDRNTVRTLIDALRVPSQELREALLDLMFELLIIKTPDWYVASLEGRRQTMYNRSTGQRKAPERSAQDSDKPEKITIIDHYIALLLVVLIDGGLIEGLTAIVEEKNQVLTRKATLLLGELLRKGNRILP |
366 |
2 | -13.000 | PF04826.13; ARMX3_MOUSE/110-363; Armadillo-like |
ali follow.. |
9 | 1 | ........SPNSDDTVLSPQELQKVLCLVEMSEKPYILEAALIALGNNAAYAFNRDIIRDLGGLPIVAKILNTRDPI---KEKALIVLNNLSVNAENQRRLKVYMNQVCDDTVTSRLNSSVQLAGLRLLTNMTVTNEYQHILANSISDFFRLFSAG---NEETKLQVLKLLLNLAENPAMTRELLRAQVPSSLGSLF---------NKKEYKEVILKLLIIFENINDNFKWEENEPAQNHFSEGSLFFFLKEFQVCADKV.......................................................................................................... |
238 |
3 | -12.900 | PF10508.9; A7SP09_NEMVE/2-505; Proteasome non-ATPase 26S subunit |
ali follow.. |
11 | 106 | ELERCSGTVNGVLALMDKEDLLSYIARGM-ADEHLKNAQIASNVFTNLAKHEAGLKVLFDSHLQSEFNALLK---TKDTVRMRVYDMYITVQAHSPKAFDVCESGIFEKLISELDGRDVLVQMNCLELLTKLASISPEYLDQKGVVTKLNNLLLEVETDP--LITLIIPGIIKFFGTLATAHPLETTQQYPQFLEQTYSM-------SCGDPTLMPIAMETIGVIAHSEDGVFNNQGRNKHIMKTIFGHATSSQVDLRKRALEALASIFYSEQLTPSEELCEFAKVLYKNMAAAPLEAIFTVAKQPFEELRCSALCLLRSLARYMINCPGFLEYLLDRRTEFEKSGKEHKYDLIKELVH....... |
465 |
4 | -10.900 | PF05804.12; KIFA3_HUMAN/13-720; Kinesin-associated protein (KAP) |
ali follow.. |
10 | 272 | YLLLNLAEDTRTELKMRNKNIVHMLVK-ALDRDNFELLILVVSFLKKLSIFMENKNDMVEMDIVEKLVKMIPCEHED---LNITLRLLLNLSFDTGLRNKMVQVGLLPKLTALLGNDNYKQIAMCVLYHISMDDRFKSMFAYTDCIPQLMKMLFECS--DERIDLELISFCINLAANKRNVQLICEGNGLKMLMKRALKIRNISQHDGPTKNLFIDYVGDLAAQISND---LANLTIPDLDLVPYLKDKLKPGAAE-DDLVLEVVIMIGTVSMDDSCAALLAKSGIIPALIELLNAQQEDDEFVCQIIYVFYQMVFH--ATRDVIIKETQAPAYLIDLMHDKNNEIRKVCDNTLDIIA........ |
649 |
5 | -7.990 | PF05918.11; D7TJH2_VITVI/11-547; Apoptosis inhibitory protein 5 (API5) |
ali follow.. |
9 | 2 | ...................EKLYEYGERLNEAKDKSQNVEDYRGI-------------------------IAAAKGSIKAKQLAAQLIPRFFKFFPD----LSDAAVDSHLDLCEEEELGVRVQAIRGLPLFCKDTPEYVSKI--VDILAQLLTAEENVERDAVHKALLSLLRQ-VDDPSTDENLREKVLNFIRDKVFPLKAELLKPQEQMERHI---TNLIKKSLED------VTGAEFKMFMDFLRSLTLFGEKAPPERVQELIEII-----GQADLDAQFNVSDGDHIDRLISCLYMALPFFVRGASNSKFLNYLNKHIIPVFDKLDLLKNLAESSPYSAPQDSRQ---ILPSVVQLLKKYMP |
321 |
6 | -7.850 | PF12231.8; Q5BCS0_EMENI/131-504; Rap1-interacting factor 1 N terminal |
ali follow.. |
10 | 15 | QFFGALRAYEKLPTEEEILHKMSLIAEFIQRDLDTNLVIQALKLSVVLVWHPQISPQLPDEFKLFLIEHSVVCLESENLPKSVVTHYL--VLSTQKFPARIITAARTTRILGMLHSITDRVKGNRLMIYERLFDVAKPTFLAL--MDHLISGLLHQIKNVRLNALELGFNVYMASGSNS-----TLSKTLRDIFDRPLANNRKLVSEVSERMSRMMSNPETGEHVPQIWGVITLLLRSKRFNVLVLQKCFNCNDPEIKSKAIGNWNRFV................................................................................................. |
304 |
7 | -7.370 | PF17741.1; A0A151PBS4_ALLMI/1-268; Family of unknown function (DUF5578 topsan) |
ali follow.. |
12 | 13 | .........................LLAFLQEWDNAGRAARSRILDNFIEANQGLELEFSQGASLFLARLTAMNGTCLDQLLKAIGIFLSAASGHRYLIEFLEVGGVLTLLEILGLSQEEDKKESIKLLQLVANAGRKLICESYGVRSIAEFMASS--KSEKAQRQVQILLDSLGHGNPKYQNQVYKGLIALL--------------PCTSPHAQQLSLQTLRVVQAI--------KSHPSIVEAVLGVLRSMELEVQYEAIQLIKDLT................................................................................................. |
250 |
8 | -7.350 | PF17822.1; G3S7I6_GORGO/1-229; Family of unknown function (DUF5584 topsan) |
ali follow.. |
12 | 10 | ...................QIWVKMYGYFAGLCRRLQKFWRVTVKGFFVKKKEKKIPSAETYF-VVLGQVLMNESLPIEKRAQAAQKIGLLAFTGGPPAGNFAAEYMEEVAHLLQDEEPKIKILLLQSVACWCYLNPKRAKSLQFIPILISFFEGRFNSYLLLKFWTCYVLSVMTNNLSCVKELKDHSALKYHLQMLAA....................................................................................................................................................................... |
207 |
9 | -7.180 | PF07539.12; E5AF73_LEPMJ/886-1482; Down-regulated in metastasis |
ali follow.. |
11 | 9 | AMLSVFAKFQNPK-VLYRTDEVRQALLALLSNGDVDIQKAALKALSAVIAHQEQLLNLLDDA-DELPLFLSDGKLHDD-EVAHILPIVLRLLSGKRGLESKRKAVFVGLKNRFGDEAIHQFLDIAFGPLSRISLIQNSSLDEEGMLNLLDDLLGTLENTFAPFTSAVVDPVLYCAQTSLLKAVRQRALHLAKLFTNSPDFDWGLYMQAEQLPIETAQSVSGILRLFAAWS-ALFLVEYNKDVLIKAIDCLDVPSDVVRCFVLEEIIRNIVFLVTNQGATTTTESKLLQNRVQTEIIQQYSNVMLSRVGNSGVQTVADMAPYVTGSVEARSMIEIATFLLRQPAKRVNSRTKL---GLLKILHEFIK |
444 |
10 | -6.680 | PF08045.11; E9DYC2_METAQ/1-287; Cell division control protein 14, SIN component |
ali follow.. |
12 | 105 | .........................................................................DGQNDLLILSALDLIQGVLLLHPPSKTLFSRQNMNLLLDLLEPFNCAIQSATLLTLVVALIDTPRTFEGLDGLLTVTSLFKSRSTSREVKLKLVEFLYCYLMPETPSIPRADQRDSVPAMLQRSPS-----KLAGAFNAESRRKRAGSSGLVTLTTEEKQELLSRHLSSVEDLVKDLK................................................................................................................... |
282 |